Illinois Center for Clinical Research

Chicago, Illinois 60622

0 studies enrolling now · 4 studies all time

What they study most

Chronic Low Back Pain, Chronic Nonmalignant and Nonneuropathic Pain, Diarrhea Predominant Irritable Bowel Syndrome, Irritable Bowel Syndrome

Studies at this site

• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome — Completed